CSF tau reflects long-term outcome of patients with idiopathic normal pressure hydrocephalus: a longitudinal retrospective study.
Objective: To predict long-term clinical outcome of iNPH patients through a panel of neurodegeneration-related CSF biomarkers. Background: Idiopathic normal pressure hydrocephalus (iNPH) is a neurodegenerative…Tau PET imaging in a patient with progressive supranuclear palsy-parkinsonism-a case report
Objective: Early detection of the brain tau deposition in patients with progressive supranuclear palsy-parkinsonism (PSP-P) by 18F-PMPBB3 positron emission tomography (PET) imaging. Background: PSP is…Creation of a biobank of patients with Progressive Supranuclear Palsy and Corticobasal Syndrome in Argentina
Objective: To generate a longitudinal cohort study and a research-ready biobank of Argentinian patients with corticobasal syndrome (CBS) and progressive supranuclear palsy (PSP). Background: Corticobasal…Amyloid status differentiates synaptic loss and atrophy in Corticobasal Syndrome.
Objective: In this observational/cross-sectional study, we tested whether the degree and extent of in vivo synaptic loss differed in patients with corticobasal syndrome according to…CBS presenting rapidly progressive anterior operculum syndrome with suggested background pathology of 4-repeat tauopathy by tau PET: A case report
Objective: Report of a case with suspected TDP-43 proteinopathy as the pathological background in the early stage of the disease, and a final diagnosis of…Probable Four-repeat tauopathy criteria in Corticobasal Syndrome: diagnostic accuracy, clinical features and imaging biomarkers
Objective: To compare the “probable four-repeat (4R)-tauopathy” criteria[1] with the clinical research(cr) criteria for corticobasal degeneration (CBD) [2] regarding diagnostic accuracy to predict a negative…Variability in Age of Onset, Age of Diagnosis and Age of Death for Progressive Supranuclear Palsy Patients Among Three Racial Groups in Hawai`i
Objective: To examine if differences in age of symptom onset, age of diagnosis, age of death, and number of years lived after diagnosis exist for…No association between naturally occurring plasma tau autoantibodies and movement disorders
Objective: To determine if there is an association between the presence of naturally occurring plasma tau autoantibodies and a movement disorder diagnosis. Background: The microtubule-associated…CSF biomarkers in neurodegenerative parkinsonism can distinguish between multiple system atrophy and 4-repeat tauopathies, but not between disease with Lewy bodies and multiple system atrophy
Objective: To assess the usefulness of a defined set of blood-based and cerebrospinal fluid-based biomarkers in the differential diagnosis of neurodegenerative proteinopathies. Background: The diagnostic…Complications in Patients with Progressive Supranuclear Palsy
Objective: This study elucidated the incidence and features of complications in patients with progressive supranuclear palsy (PSP). Background: PSP is a progressive neurodegenerative disorder accompanied…
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- 6
- …
- 13
- Next Page »